Focused ultrasound is emerging as a powerful therapy to noninvasively reduce motor symptoms and improve the quality of life for people with Parkinson’s disease (PD).

Focused ultrasound is emerging as a powerful therapy to noninvasively reduce motor symptoms and improve the quality of life for people with Parkinson’s disease (PD). Following the FDA’s July 2025 approval of bilateral focused ultrasound for PD, patients may now receive focused ultrasound treatment on both sides of their brain (in separate sessions six months apart).